藥品參考
Reboxetine
Reboxetine is a medicine in the class central nervous system. It is used for depression.
- 藥物類別: Central Nervous System
- 用途: depression
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Central Nervous System
- 常見劑型
- 錠劑
- 常見規格
- 4 mg
- 商品名
- 2
- 國家與市場
- 2
用途
作用方式
Reboxetine is primarily used to treat depression but has also been found useful in the treatment of narcolepsy and panic disorders. Reboxetine is a selective inhibitor of noradrenaline reuptake. It inhibits noradrenaline reuptake in vitro to a similar extent to the tricyclic antidepressant desmethylimipramine.
成人常用劑量（仿單摘要）
The recommended therapeutic dose is 4 mg twice a day (b.i.d.) i.e.8 mg/day administered orally, maximum daily dose should not exceed 12 mg/day.
懷孕與哺乳
- 懷孕
- Unknown No trial data; a very limited number of exposed pregnancies showed no adverse effects. Animal studies showed no harm apart from impaired growth in rat pups. Not approved in the US. UK label: use only if benefits outweigh risks; better-studied antidepressants are preferred.
- 哺乳
- Unknown Passes into milk in low amounts; no adverse effects reported in breastfed infants (doses up to 10 mg daily). UK label: consider if benefits outweigh the risk. LactMed: use with careful infant monitoring. SSRIs such as sertraline have more data.
已通報的副作用
- Dry mouth
- Insomnia
- Constipation
- Decreased appetite
- Dizziness
- Agitation
哪些人需要特別留意
- The starting dose in patients with renal or hepatic insufficiency should be 2 mg b.i.d which can be increased based on patient tolerance.
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
同類別的其他藥品
常見問題
What is Reboxetine used for?
Reboxetine is a medicine in the class central nervous system. It is used for Depression.
What side effects have been reported with Reboxetine?
Dry mouth, Insomnia, Constipation, Decreased appetite, Dizziness, Agitation.
Can Reboxetine be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No trial data; a very limited number of exposed pregnancies showed no adverse effects. Animal studies showed no harm apart from impaired growth in rat pups. Not approved in the US. UK label: use only if benefits outweigh risks; better-studied antidepressants are preferred. Breastfeeding: Unknown. Passes into milk in low amounts; no adverse effects reported in breastfed infants (doses up to 10 mg daily). UK label: consider if benefits outweigh the risk. LactMed: use with careful infant monitoring. SSRIs such as sertraline have more data.
What does Reboxetine interact with?
MediHelp does not list a checked interaction for Reboxetine yet. Always tell your pharmacist about every medicine you take.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
